| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
| mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
1 |
| mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |
| mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
1 |
| mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
1 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.0023 |
1 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.0025 |
1 |